Athenex Inc 's ability to collect accounts receivable sequentially worsen to 3.31, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Athenex Inc 's Accounts Receivable average collection period in the Dec 31 2022 quarter, has increased to 110 days, from 91 days, in the Sep 30 2022 quarter.

If we take a look into Healthcare sector 608 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2022 from 3293 to 3957.

What is Receivable Turnover Ratio?
What is Athenex Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ATNX Receivables Turnover Ratio	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter
Y / Y Receivable Change	22.33 %	-2.5 %	52.24 %	46.64 %	-3.5 %
Y / Y Revenue Change	-67.71 %	3.82 %	43.76 %	-27.55 %	14.34 %
Receivable Turnover Ratio (TTM)	3.31	4.02	3.95	4.02	4.86
ATNX's Total Ranking	# 3957	# 3293	# 3357	# 3344	# 3461
Accounts Receivable average collection period days	110	91	92	91	75
Seq. Receivable Change	-15.33 %	-2.7 %	14.25 %	29.97 %	-32.52 %
Seq. Revenue Change	-75.99 %	6.39 %	6.03 %	19.2 %	-22.79 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 218
Healthcare Sector	# 609
Overall Market	# 3957

Receivable Turnover Ratio Statistics
High	Average	Low
11.6	6.12	3.31
(Sep 30 2018)		(Dec 31 2022)

ATNX Company Profile • Back to ATNX Efficiency Comparisons • Compare ATNX Receivables Turnover Ratio to its Competitors

Financial Statements
Athenex Inc 's Accounts Receivable	$ 28 Millions	Visit ATNX's Balance sheet
Athenex Inc 's Sales TTM	$ 103 Millions	Visit ATNX's Income Statement
Sources of ATNX's Revenues		Visit ATNX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ATNX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ATNX's Growth Rates	ATNX's Roa	ATNX's Inventory Turnover Ratio	ATNX's Dividend Comparisons
ATNX's Profitability Ratios	ATNX's Roi	ATNX's Asset Turnover Ratio	ATNX's Dividend Growth
ATNX's Valuation Ratios	ATNX's Roe	ATNX's Financial Strength Ratios	ATNX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2022	Receivable at quarter ending Dec 31 2022
G Medical Innovations Holdings Ltd	10.02	$ 4.420 Millions	$ 0.441 Millions
Cerus Corporation	9.98	$ 287.164 Millions	$ 28.765 Millions
Surmodics Inc	9.95	$ 101.881 Millions	$ 10.235 Millions
Sunlink Health Systems Inc	9.95	$ 46.018 Millions	$ 4.624 Millions
Intercept Pharmaceuticals inc	9.95	$ 315.146 Millions	$ 31.673 Millions
Cartesian Therapeutics Inc	9.92	$ 110.777 Millions	$ 11.167 Millions
Atrion Corporation	9.91	$ 183.506 Millions	$ 18.523 Millions
Immucell Corporation	9.87	$ 18.568 Millions	$ 1.882 Millions
Procyon Corporation	9.87	$ 4.681 Millions	$ 0.475 Millions
Barinthus Biotherapeutics Plc	9.74	$ 44.703 Millions	$ 4.590 Millions
Adc Therapeutics Sa	9.73	$ 350.018 Millions	$ 35.959 Millions
United Therapeutics Corporation	9.73	$ 1,936.300 Millions	$ 199.000 Millions
Rockwell Medical inc	9.72	$ 70.049 Millions	$ 7.209 Millions
Milestone Scientific Inc	9.59	$ 8.806 Millions	$ 0.919 Millions
Viemed Healthcare Inc	9.53	$ 138.832 Millions	$ 14.562 Millions
Myomo Inc	9.51	$ 15.555 Millions	$ 1.635 Millions
Sanara Medtech Inc	9.42	$ 45.843 Millions	$ 4.868 Millions
Utah Medical Products Inc	9.41	$ 52.281 Millions	$ 5.557 Millions
Vbi Vaccines Inc	9.35	$ 1.082 Millions	$ 0.116 Millions
Heska Corporation	9.33	$ 257.307 Millions	$ 27.584 Millions
Alpha Pro Tech Ltd	9.28	$ 61.981 Millions	$ 6.678 Millions
Q Biomed inc	9.09	$ 0.284 Millions	$ 0.031 Millions
Sunshine Biopharma Inc	9.09	$ 4.346 Millions	$ 0.478 Millions
Ardelyx inc	9.09	$ 52.158 Millions	$ 5.740 Millions
Anaptysbio Inc	9.04	$ 10.287 Millions	$ 1.138 Millions
Novavax inc	9.00	$ 1,981.872 Millions	$ 220.136 Millions
Protalix Biotherapeutics inc	9.00	$ 47.638 Millions	$ 5.292 Millions
Nexgel Inc	8.91	$ 2.048 Millions	$ 0.230 Millions
Lensar Inc	8.87	$ 35.358 Millions	$ 3.986 Millions
Harmony Biosciences Holdings inc	8.86	$ 437.855 Millions	$ 49.440 Millions

Date modified: 2026-09-08T15:10:52+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.